Furthermore, the application of a miR-145-5p inhibitor can reverse the inhibitory effects of BRE-AS1 overexpression on cancer cell behavior, confirming that the regulatory function of BRE-AS1 relies on its molecular interactions with miR-145-5p. This evidence concerns the gene BABAM2 and cancer.